![Anju Chatterji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anju Chatterji
Technik-/Wissenschafts-/F&E-Leiter bei
HILLEVAX, INC.
Profil
Anju Chatterji currently works at HilleVax, Inc., as Chief Technology Officer from 2023.
Dr. Chatterji also formerly worked at Grifols Biologicals, Inc., as Director-Technical Development and Catalyst Biosciences, Inc., as Senior VP-Biologics Development & Manufacturing.
Dr. Chatterji received her doctorate degree from Indian Agricultural Research Institute.
Aktive Positionen von Anju Chatterji
| Unternehmen | Position | Beginn |
|---|---|---|
| HILLEVAX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
Ehemalige bekannte Positionen von Anju Chatterji
| Unternehmen | Position | Ende |
|---|---|---|
Grifols Biologicals, Inc.
 Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Technik-/Wissenschafts-/F&E-Leiter | - |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | - |
Ausbildung von Anju Chatterji
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Indian Agricultural Research Institute
 Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
